The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium

Detalhes bibliográficos
Autor(a) principal: Mutapi,Francisca
Data de Publicação: 2002
Outros Autores: Mduluza,Takafira, Ndhlovu,Patricia D
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Memórias do Instituto Oswaldo Cruz
Texto Completo: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762002000900034
Resumo: The effect of praziquantel treatment on the age-antibody relationship was studied in 174 children aged between 6 and 17 years from a schistosome endemic area in Zimbabwe. The children were co-infected with Schistosoma mansoni and S. haematobium with infection prevalences of 74% and 53% respectively. Antibody levels for the isotypes IgA, IgE, IgM, IgG1, IgG2, IgG3 and IgG4, directed against soluble egg antigen were measured using an indirect ELISA assay. Treatment resulted in a significant increase in levels of IgG2 and IgG3 while levels of IgA decreased significantly. In untreated children there were significant decreases in levels of IgG4. Treatment also resulted in significant alteration in the age-antibody profiles for the isotypes IgE, IgM, IgG1 and IgG2 in treated children but not in untreated children. The results are discussed in the context of factors believed to give rise to the age-antibody relationship; i.e. age-related exposure patterns, age-related development of acquired immunity, age-related hormonal changes and age-related changes in innate susceptibility to infection.
id FIOCRUZ-4_08fd5f63547ca32aa61514a3ce04d11b
oai_identifier_str oai:scielo:S0074-02762002000900034
network_acronym_str FIOCRUZ-4
network_name_str Memórias do Instituto Oswaldo Cruz
spelling The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobiumSchistosoma mansoniSchistosoma haematobiumantibodyage-infection experiencetreatmentThe effect of praziquantel treatment on the age-antibody relationship was studied in 174 children aged between 6 and 17 years from a schistosome endemic area in Zimbabwe. The children were co-infected with Schistosoma mansoni and S. haematobium with infection prevalences of 74% and 53% respectively. Antibody levels for the isotypes IgA, IgE, IgM, IgG1, IgG2, IgG3 and IgG4, directed against soluble egg antigen were measured using an indirect ELISA assay. Treatment resulted in a significant increase in levels of IgG2 and IgG3 while levels of IgA decreased significantly. In untreated children there were significant decreases in levels of IgG4. Treatment also resulted in significant alteration in the age-antibody profiles for the isotypes IgE, IgM, IgG1 and IgG2 in treated children but not in untreated children. The results are discussed in the context of factors believed to give rise to the age-antibody relationship; i.e. age-related exposure patterns, age-related development of acquired immunity, age-related hormonal changes and age-related changes in innate susceptibility to infection.Instituto Oswaldo Cruz, Ministério da Saúde2002-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762002000900034Memórias do Instituto Oswaldo Cruz v.97 suppl.1 2002reponame:Memórias do Instituto Oswaldo Cruzinstname:Fundação Oswaldo Cruzinstacron:FIOCRUZ10.1590/S0074-02762002000900034info:eu-repo/semantics/openAccessMutapi,FranciscaMduluza,TakafiraNdhlovu,Patricia Deng2020-04-25T17:48:59Zhttp://www.scielo.br/oai/scielo-oai.php0074-02761678-8060opendoar:null2020-04-26 02:11:39.051Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruztrue
dc.title.none.fl_str_mv The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
title The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
spellingShingle The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
Mutapi,Francisca
Schistosoma mansoni
Schistosoma haematobium
antibody
age-infection experience
treatment
title_short The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
title_full The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
title_fullStr The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
title_full_unstemmed The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
title_sort The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
author Mutapi,Francisca
author_facet Mutapi,Francisca
Mduluza,Takafira
Ndhlovu,Patricia D
author_role author
author2 Mduluza,Takafira
Ndhlovu,Patricia D
author2_role author
author
dc.contributor.author.fl_str_mv Mutapi,Francisca
Mduluza,Takafira
Ndhlovu,Patricia D
dc.subject.por.fl_str_mv Schistosoma mansoni
Schistosoma haematobium
antibody
age-infection experience
treatment
topic Schistosoma mansoni
Schistosoma haematobium
antibody
age-infection experience
treatment
dc.description.none.fl_txt_mv The effect of praziquantel treatment on the age-antibody relationship was studied in 174 children aged between 6 and 17 years from a schistosome endemic area in Zimbabwe. The children were co-infected with Schistosoma mansoni and S. haematobium with infection prevalences of 74% and 53% respectively. Antibody levels for the isotypes IgA, IgE, IgM, IgG1, IgG2, IgG3 and IgG4, directed against soluble egg antigen were measured using an indirect ELISA assay. Treatment resulted in a significant increase in levels of IgG2 and IgG3 while levels of IgA decreased significantly. In untreated children there were significant decreases in levels of IgG4. Treatment also resulted in significant alteration in the age-antibody profiles for the isotypes IgE, IgM, IgG1 and IgG2 in treated children but not in untreated children. The results are discussed in the context of factors believed to give rise to the age-antibody relationship; i.e. age-related exposure patterns, age-related development of acquired immunity, age-related hormonal changes and age-related changes in innate susceptibility to infection.
description The effect of praziquantel treatment on the age-antibody relationship was studied in 174 children aged between 6 and 17 years from a schistosome endemic area in Zimbabwe. The children were co-infected with Schistosoma mansoni and S. haematobium with infection prevalences of 74% and 53% respectively. Antibody levels for the isotypes IgA, IgE, IgM, IgG1, IgG2, IgG3 and IgG4, directed against soluble egg antigen were measured using an indirect ELISA assay. Treatment resulted in a significant increase in levels of IgG2 and IgG3 while levels of IgA decreased significantly. In untreated children there were significant decreases in levels of IgG4. Treatment also resulted in significant alteration in the age-antibody profiles for the isotypes IgE, IgM, IgG1 and IgG2 in treated children but not in untreated children. The results are discussed in the context of factors believed to give rise to the age-antibody relationship; i.e. age-related exposure patterns, age-related development of acquired immunity, age-related hormonal changes and age-related changes in innate susceptibility to infection.
publishDate 2002
dc.date.none.fl_str_mv 2002-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762002000900034
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762002000900034
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0074-02762002000900034
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
dc.source.none.fl_str_mv Memórias do Instituto Oswaldo Cruz v.97 suppl.1 2002
reponame:Memórias do Instituto Oswaldo Cruz
instname:Fundação Oswaldo Cruz
instacron:FIOCRUZ
reponame_str Memórias do Instituto Oswaldo Cruz
collection Memórias do Instituto Oswaldo Cruz
instname_str Fundação Oswaldo Cruz
instacron_str FIOCRUZ
institution FIOCRUZ
repository.name.fl_str_mv Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruz
repository.mail.fl_str_mv
_version_ 1669937688097062912